Fund
Finchley Healthcare Ventures
0 Followers
Innovative private companies developing breakthrough therapies for major unmet medical needs
About
Innovative private companies developing breakthrough therapies for major unmet medical needs. Last or second-to-last private financing round strategy. Evergreen structure for multiple rounds and IPOs.
Location
Montréal, Quebec
Work
The 50 · Late Private · Life Sciences
Stage
Late Private
Socials
- n/a
- Type
- The 50
- Stage
- Late Private
- AUM
- US$86M
- Source
- The 50: Canadian VC Ecosystem Guide 2026
Investment thesis
Innovative private companies developing breakthrough therapies for major unmet medical needs. Last or second-to-last private financing round strategy. Evergreen structure for multiple rounds and IPOs.
What makes them unique
Affiliation with Pharmascience providing strategic support and resources beyond capital.
Team
- Leadership team with pharmaceuticals, VC, and financial management experience
Select portfolio
Company
Aug 2026